Rosuvastatin was equally effective in preventing a first cardiovascular event across categories of hsTnI ( aHR range , @-@ @ ) and BNP ( aHR range , @-@ @ ) with no statistically significant evidence of interaction ( P for interaction = @ and @ , respectively ) .